Zoekresultaten - Takao Orii

  • Toon 1 - 2 resultaten van 2
Verfijn jouw resultaten
  1. 1
    Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria

    Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria door Hirokazu Nakayama, Kensuke Usuki, Hirotoshi Echizen, Ryuichi Ogawa, Takao Orii

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Establishment of the MID‐NET<sup>®</sup> medical information database network as a reliable and valuable database for drug safety assessments in Japan

    Establishment of the MID‐NET<sup>®</sup> medical information database network as a reliable and valuable database for drug safety assessments in Japan door Mitsune Yamaguchi, Satomi Inomata, Sayoko Harada, Yu Matsuzaki, Maiko Kawaguchi, Mayuko Ujibe, Mari Kishiba, Yoshiaki Fujimura, Michio Kimura, Koichiro Murata, Naoki Nakashima, Masaaki Nakayama, Kazuhiko Ohe, Takao Orii, Eizaburo Sueoka, T. Suzuki, Hideto Yokoi, Fumitaka Takahashi, Yoshiaki Uyama

    Gepubliceerd in 2019
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: